Indaptus Therapeutics Inc

1
NAS:INDP (USA)  
$ 2.25 -0.25 (-10.04%) 11:09 PM EST
At Loss
P/B:
1.56
Market Cap:
$ 19.21M
Enterprise V:
$ 7.99M
Volume:
54.51K
Avg Vol (2M):
117.40K
Volume:
54.51K
At Loss
Avg Vol (2M):
117.40K

Business Description

Indaptus Therapeutics Inc
NAICS : 541714 SIC : 2834
ISIN : US45339J1051
Description
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
Name Current Vs Industry Vs History
Cash-To-Debt 76.35
Equity-to-Asset 0.81
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -43
3-Year EPS without NRI Growth Rate -40.3
3-Year FCF Growth Rate -37.4

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 44.43
9-Day RSI 50.84
14-Day RSI 53.12
6-1 Month Momentum % -28
12-1 Month Momentum % 12.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.05
Quick Ratio 5.05
Cash Ratio 4.82

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.8
Shareholder Yield % -0.43
Name Current Vs Industry Vs History
ROE % -83.96
ROA % -73.6
ROIC % -876.86
ROC (Joel Greenblatt) % -9038.63
ROCE % -88.75

Financials (Next Earnings Date:2024-05-10 Est.)

INDP's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:INDP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Indaptus Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.84
Beta 0
Volatility % 85.34
14-Day RSI 53.12
14-Day ATR ($) 0.268432
20-Day SMA ($) 2.170495
12-1 Month Momentum % 12.5
52-Week Range ($) 1.56 - 4.08
Shares Outstanding (Mil) 8.54

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Indaptus Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Indaptus Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Indaptus Therapeutics Inc Frequently Asked Questions

What is Indaptus Therapeutics Inc(INDP)'s stock price today?
The current price of INDP is $2.25. The 52 week high of INDP is $4.08 and 52 week low is $1.56.
When is next earnings date of Indaptus Therapeutics Inc(INDP)?
The next earnings date of Indaptus Therapeutics Inc(INDP) is 2024-05-10 Est..
Does Indaptus Therapeutics Inc(INDP) pay dividends? If so, how much?
Indaptus Therapeutics Inc(INDP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1